Unlocking the Power of High-Dimensional Simulations with STDE 
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
FLORHAM PARK, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived...
Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WIXOM, Mich., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the...
Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic...
Rezolute Reports First Quarter Fiscal 2022 Financial Results and Highlights Recent Company Progress
REDWOOD CITY, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies...
ReWalk Robotics to Present at the H.C. WAINWRIGHT 7th Annual Israel Virtual Conference
MARLBOROUGH, Mass., BERLIN Germany and YOKNEAM ILIT, Israel, Nov. 12, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the...
Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
SAN JOSE, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a...
Assertio Holdings, Inc. Announces Preliminary Court Approval of Shareholder Derivative Settlement
LAKE FOREST, Ill., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced...
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
NEWTOWN, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech...
Chinmayam Consultants Mark 15th Year Anniversary Coaching Top Leaders Through Business Transformation
Sacramento, California--(Newsfile Corp. - November 12, 2021) - Launched in 2007, Chinmayam Consultants has advised top business leaders in the verticals of...
Sanara MedTech Inc. Announces Third Quarter 2021 Results and Business Update
FORT WORTH, TX / ACCESSWIRE / November 12, 2021 / Sanara MedTech Inc.Based in Fort Worth, Texas, Sanara MedTech Inc....
Zomedica Announces Third Quarter 2021 Financial Results
ANN ARBOR, MI / ACCESSWIRE / November 12, 2021 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health...
ModMed® Surpasses 100 Million Patient Encounters in Eye Care
The company continues to focus on innovating clinical workflow efficiency across the practice for providers to achieve greater ROI. NEW...
Impact Fusion International Announced today that Acra Investments Reached an Agreement in Principle with South Richmond Realty to Purchase the 62-acre Napoleonville Property
NAPOLEONVILLE, LA / ACCESSWIRE / November 12, 2021 / Impact Fusion International, Inc. (OTC PINK:IFUS):Impact Fusion International, Inc. a company...
iTolerance, Inc. to Present at Virtual Investor Roundtable Event
Live moderated video webcast discussion among members of management and Key Opinion Leaders, Andrés García, PhD, Haval Shirwan, PhD, and...
Altamira Therapeutics Reports Positive In vitro Efficacy Data for Bentrio Nasal Spray in Protecting Against Sars-CoV-2 Delta Variant
Significant reduction of infectious viral titer in human nasal epithelium model with either prophylactic or therapeutic applicationResults provide further confirmation...
Cannabis Suisse Corp. to Design a New IT Product “Cannabis Life” Based on Artificial Intelligence
DIETIKON, SWITZERLAND / ACCESSWIRE / November 12, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), a Nevada incorporated distribution company exercising...
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
SEATTLE, WA / ACCESSWIRE / November 12, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology...
Innovation Pharmaceuticals Conducting Full Data Analysis of Phase 2 Brilacidin COVID-19 Trial Results to Support Brilacidin’s Potential Inclusion in Government-Sponsored COVID-19 Trials
Additionally, new in vitro data also show Brilacidin targets both viral proteins and host factors, suggesting Brilacidin would be less...
IR-Med to Become Fully Reporting SEC Company
IR-Med filed an application to uplist to OTCQB New York, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK:...
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences
BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...